Yahoo
NYSE - Nasdaq Real Time Price USD

CVS Health Corporation (CVS)

90.96 +1.01 (+1.12%)
As of 10:54:34 AM EDT. Market Open.
Trade CVS on Coinbase
Chart Range Bar
Loading chart for CVS

What's happening with CVS?

9m ago
Powered by Yahoo Scout

CVS faces a major Medicare Advantage dispute that could affect approximately $2 billion in future bonus payments. The company is also preparing for its November 4, 2026, third-quarter earnings report, while expanding technology, pharmacy automation, affordable housing programs, and retail collectibles.

Powered by Yahoo Scout
  • Previous Close 89.95
  • Open 91.85
  • Bid 90.92 x 20000
  • Ask 91.03 x 10000
  • Day's Range 90.86 - 91.90
  • 52 Week Range 69.51 - 110.68
  • Volume 2,356,636
  • Avg. Volume 7,902,503
  • Market Cap (intraday) 116.335B
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) 23.94
  • EPS (TTM) 3.80
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield 2.66 (2.96%)
  • 1y Target Est 115.48
  • Morningstar Rating Rating available with Stock Picks access

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

www.cvshealth.com

219,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CVS
18.14%
S&P 500 (^GSPC)
12.59%

1-Year Return

CVS
16.32%
S&P 500 (^GSPC)
11.85%

3-Year Return

CVS
53.65%
S&P 500 (^GSPC)
87.19%

5-Year Return

CVS
20.42%
S&P 500 (^GSPC)
67.35%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 106.1B
Earnings 2.98B
Profit Margin 2.81%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
20B
40B
60B
80B
100B
-2.0%
0.0%
2.0%

Analyst Insights

View More

Analyst Price Targets

103.00
115.48 Average
90.96 Current
145.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/12/2026
Analyst Leerink Partners
Rating Action Maintains
Rating Outperform
Price Action Lowers
Price Target 119 -> 112

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.18%

  • Return on Assets (ttm)

    2.97%

  • Return on Equity (ttm)

    6.20%

  • Revenue (ttm)

    412.64B

  • Net Income Avi to Common (ttm)

    4.89B

  • Diluted EPS (ttm)

    3.80

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.96B

  • Total Debt/Equity (mrq)

    95.50%

  • Levered Free Cash Flow (ttm)

    8.08B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: